ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

GSK Gsk Plc

1,650.00
14.00 (0.86%)
Last Updated: 11:12:52
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Gsk Plc LSE:GSK London Ordinary Share GB00BN7SWP63 ORD 31 1/4P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  14.00 0.86% 1,650.00 1,649.50 1,650.00 1,656.00 1,635.00 1,642.00 1,037,950 11:12:52
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 30.33B 4.93B 1.1970 13.80 68.01B
Gsk Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker GSK. The last closing price for Gsk was 1,636p. Over the last year, Gsk shares have traded in a share price range of 1,302.60p to 1,719.80p.

Gsk currently has 4,117,033,438 shares in issue. The market capitalisation of Gsk is £68.01 billion. Gsk has a price to earnings ratio (PE ratio) of 13.80.

Gsk Share Discussion Threads

Showing 32926 to 32949 of 33100 messages
Chat Pages: 1324  1323  1322  1321  1320  1319  1318  1317  1316  1315  1314  1313  Older
DateSubjectAuthorDiscuss
06/2/2024
07:45
A few nice RNSs today...positive momentum
panache1
06/2/2024
07:06
Hoping this reaches £17 by end of week , if it ever reaches £17.50 then I can break even after 18 months of misery. Will wait till.feb 22 nd for dividend and hopefully zantac news and decide .
alibizzle
05/2/2024
16:47
Tuffymatt,

Hope you jumped into both, DGE, I did research, back in.

GSK, a punt (toss up between this and AZM), chose GSK.

1562. More luck than judgement, but your called it right, WD.

dudishes
05/2/2024
12:32
Its still way to cheap. This price in 12m time will look very cheap.
tradermichael
05/2/2024
12:22
Think long term if it drops just top up
mj19
05/2/2024
12:16
This is going up in a very 'non-FTSE-stock' kind of way !!
mister md
05/2/2024
09:49
DB raising target 1950p very good, because they are tough on price targets.
montyhedge
05/2/2024
08:38
Everything comes down to momentum with shares.
igoe104
05/2/2024
08:10
Things definitely looking up here at the moment
supermarky
05/2/2024
08:02
Deutsche Bank raises target price to 1950p from 1850p
dplewis1
02/2/2024
16:27
Cup and handle?
tradermichael
02/2/2024
15:51
this seems like a breakout
supermarky
02/2/2024
15:44
Nice to see £16 broken
rikky72
02/2/2024
10:28
It might take some more time as the profit-takers drop off and fresh buyers come in .... ;0)
tradermichael
02/2/2024
10:23
If they break 1600p hopefully thats support level and not resistance level.
montyhedge
01/2/2024
18:02
On the ADVFN chart looks to be the highest close since the demerger. In addition 2 people in the know buying shares. Hope it lasts...
pcok
01/2/2024
10:23
Hopefully we can now push on to 1620+ in the short term.

Good luck all 👍🏻

tuftymatt
01/2/2024
10:22
Yeah surely this means everyone has to get payed in settlements? So they admit liability but at that same time don't admit liability. WTF
alibizzle
01/2/2024
09:54
Not exactly defending itself is it, paying out to anyone that sues. Opening the floodgates IMO.
disc0dave46
01/2/2024
09:12
Oh well,only a few hours until Wall Street opens and we'll get a response!
steeplejack
01/2/2024
08:42
2024 Guidance

GSK expects 2024 sales to increase between 5 to 7 per cent and Adjusted Operating profit to increase between 7 to 10 per cent. Adjusted Earnings per share is expected to increase between 6 to 9 per cent. This guidance is provided at CER and excludes any contribution from COVID-19 related solutions.

The Group has made planning assumptions that we expect sales to increase between 5 to 7 per cent, with high single digit to low double-digit growth for Vaccines, low double-digit growth for Specialty Medicines and a mid-single-digit decline for General Medicines.

waldron
01/2/2024
07:13
RNS - 01.02.2024 - GSK plc (LSE/NYSE: GSK) today confirmed it has reached a confidential settlement with David Browne, resolving the case he filed in California state court. This case was set to go to trial on 20 February 2024, and instead will now be dismissed. The settlement reflects the Company's desire to avoid the distraction related to protracted litigation in this case. GSK does not admit any liability in this settlement and will continue to vigorously defend itself based on the facts and the science in all other Zantac cases.
laurence llewelyn binliner
31/1/2024
18:02
UK IIs should have been on this, this AM, after fall but all asleep as usual. Took WS-any wonder London dying as a market-no UK II support.
cumnor
31/1/2024
14:58
GSK's RSV vaccine success makes its shares look cheap

After years as a sector laggard, the company has decided to make a name for itself in immunisations

At this point, there’s no way to estimate the cost of resolving the [Zantac] saga, but with shares trading on just 10 times forward earnings for 2024, we’d argue GSK looks cheap for a company on the up. Buy.

zho
Chat Pages: 1324  1323  1322  1321  1320  1319  1318  1317  1316  1315  1314  1313  Older

Your Recent History

Delayed Upgrade Clock